Loading asset research
Voyager Therapeutics Inc. Common Stock
VYGRNasdaq · USD · StocksQuote as of · Exchange session not verified$3.19
0.00%
Today
VYGR
Loading 1D prices…
Market cap
$196.6M
Volume
276.1K
52w high
$5.5552w low
$2.94Company profile
Voyager Therapeutics Inc. Common Stock
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Lexington, MA, United States
Employees
141
Fiscal year end
1231
CIK
1640266
Session & valuation
Open$3.24
Previous close$3.19
Day high$3.28
Day low$3.15
30-day avg. volume440.2K
Outstanding shares61.6M
Diluted EPS-$2.04
Latest annual period
P/E (trailing)-1.56
P/E (forward)-2.49
Price / book1.11
Beta1.32
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| NMRANeumora Therapeutics Inc. Common Stock | $195.4M | $0.00 | — | -$1.45 | -9.21% | Buy |
| DTILPrecision BioSciences Inc. Common Stock | $197.9M | $34.3M | -133.45% | -$3.56 | -0.97% | Buy |
| ACOGAlpha Cognition Inc. Common Stock | $193.8M | $10.2M | -202.24% | -$1.18 | 0.00% | Buy |
| ARMPArmata Pharmaceuticals Inc. Common Stock | $200M | $0.00 | — | -$4.80 | +2.87% | Buy |
| CHRSCoherus Oncology Inc. Common Stock | $205.5M | $42.2M | +398.43% | $1.43 | +0.00% | Buy |